Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

SEAblings: Solidaritas di tengah perasaan “benci tapi rindu” masyarakat ASEAN

Di antara maraknya pemberitaan mengenai demonstrasi dan tuntutan kepada Dewan Perwakilan Rakyat (DPR), serta aksi protes atas tewasnya Affan Kurniawan—pengemudi ojek daring (ojol) yang meninggal...

Model baru restorasi agar tambak udang bisa berdampingan dengan pemulihan mangrove

● Mangrove dalam tambak tidak selalu menguntungkan.● Jika ditanam terlalu rapat di dalam tambak, mangrove justru menurunkan produksi udang.● Riset menunjukkan, sabuk hijau mangrove d...

Gagal mendamaikan: ASEAN memang dirancang bukan untuk menyelesaikan konflik regional

Shutterstock● Struktur ASEAN tidak dirancang untuk menangani ketegangan regional.● Keheningan ASEAN bukan kelemahan, melainkan strategi menjaga stabilitas politik dan integrasi ekonomi eli...